Cerebellar stroke syndrome. Cerebellar stroke syndrome
Conditions
Interventions
Intervention 1: Intervention group: patients in the intervention group will receive 30 mg melatonin following acute ischemic stroke for 5 days. Intervention 2: Control group: patients in the control g
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults over the age of 18 and diagnose with acute ischemic stroke according to brain CT scan findings NIHSS more than 4
Exclusion criteria
Exclusion criteria: Hemorrhagic stroke Lacunar infarct TIA NIHSS more than 25 Pregnancy Lactation Severe hepatic insufficiency History of apnea
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glutathione serum level. Timepoint: days 0 and 5th of the study. Method of measurement: Spectroscopy.;Antioxidant serum levels. Timepoint: at days 0 and 5th of the study. Method of measurement: Spectroscopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Disability following stroke. Timepoint: At days 0, discharge and month three of the study. Method of measurement: According to mRS.;Tolerability of melatonin. Timepoint: During the study period. Method of measurement: History taking. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMazandaran University of Medical Sciences
Mazandaran University of Medical Sciences
Outcome results
None listed